Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Promod Haque currently holds 12,458,934 shares of Health Catalyst, Inc. (HCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Promod Haque has been a net seller of HCAT stock. They have purchased $29.0M and sold $67.7M worth of shares.
Promod Haque's most recent insider trade was on Nov 2, 2021, when they sold 11,552,940 shares at $0.00 per share.
Promod Haque serves as Executive at Health Catalyst, Inc. (HCAT). They have executed 501 insider transactions totaling $96.7M over their tenure at the company.
Promod Haque holds the position of Executive at Health Catalyst, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Promod Haque has shown a selling trading pattern, with $29.0M in total purchases and $67.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Promod Haque was on Aug 3, 2015, when they sold $6.4M worth of CYNI shares. This transaction involved 1,140,300 shares at $5.65 per share.
Promod Haque currently owns 12,458,934 shares of Health Catalyst, Inc. (HCAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Promod Haque's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Promod Haque has 501 Form 4 filings on record as an insider at Health Catalyst, Inc..
Set alerts for Promod Haque and 40,000+ other insiders.